Stockscreener 앱 받기
50.21
0.38%
0.19
시간 외 거래:
51.21
1.00
+1.99%
전일 마감가:
$50.02
열려 있는:
$49.92
하루 거래량:
555.14K
Relative Volume:
0.49
시가총액:
$1.45B
수익:
$915.25M
순이익/손실:
$131.14M
주가수익비율:
11.23
EPS:
4.472
순현금흐름:
$96.71M
1주 성능:
+2.07%
1개월 성능:
+12.55%
6개월 성능:
-33.74%
1년 성능:
-59.68%
1일 변동 폭
$49.02
$50.39
1주일 범위
$48.21
$52.49
52주 변동 폭
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
명칭
Inspire Medical Systems Inc
전화
763-957-5037
주소
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
50.21 | 1.47B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-01-22 | 다운그레이드 | Truist | Buy → Hold |
| 2025-12-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | 업그레이드 | Truist | Hold → Buy |
| 2025-11-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-09-02 | 개시 | Evercore ISI | Outperform |
| 2025-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | 다운그레이드 | Truist | Buy → Hold |
| 2024-11-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-04-19 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-19 | 개시 | Morgan Stanley | Overweight |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2024-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-12-13 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-11-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-11-03 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 개시 | JP Morgan | Overweight |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-07-15 | 개시 | Goldman | Buy |
| 2020-06-18 | 재확인 | Piper Sandler | Overweight |
| 2020-05-18 | 개시 | Lake Street | Buy |
| 2020-04-28 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 개시 | Piper Sandler | Overweight |
| 2020-01-28 | 개시 | Oppenheimer | Underperform |
| 2020-01-27 | 개시 | Oppenheimer | Underperform |
| 2019-11-06 | 업그레이드 | Berenberg | Sell → Hold |
| 2019-02-05 | 개시 | Dougherty & Company | Buy |
| 2018-11-28 | 개시 | Berenberg | Sell |
| 2018-10-29 | 개시 | Leerink Partners | Outperform |
| 2018-05-29 | 개시 | Guggenheim | Buy |
| 2018-05-29 | 개시 | Stifel | Buy |
| 2018-05-29 | 개시 | Wells Fargo | Outperform |
모두보기
Inspire Medical Systems Inc 주식(INSP)의 최신 뉴스
UBS Downgrades Inspire Medical Systems to Sell From Neutral, Cuts Price Target to $39 From $67 - marketscreener.com
UBS initiates Inspire Medical stock with Sell rating on growth concerns - Investing.com
INSP|Inspire Medical Systems Inc|Price:50.920|Chg%:+1.730 - TradingKey
Form 4 Inspire Medical Systems Inc For: 27 July By Investing.com - Investing.com Canada
Inspire Medical Systems (NYSE: INSP) awards 5,631 RSUs to board member Carrel - Stock Titan
Inspire Medical Systems, Inc. (INSP) director files initial Form 3 with no holdings - Stock Titan
AtriCure CEO Carrel joins Inspire Medical board of directors - MassDevice
Inspire Medical (2DR) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems adds AtriCure CEO to board - Investing.com
Inspire Medical Systems adds AtriCure CEO to board By Investing.com - Investing.com South Africa
Inspire's New Director Comes From AtriCure, Which Helped Over 1M Patients - Stock Titan
Inspire Medical Systems Inc (INSP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inspire Medical Systems Inc (INSP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inspire Medical Systems Inc (INSP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inspire Medical (2DR) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical (2DR) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo! Finance Canada
TradingKey - TradingKey
INSP|Inspire Medical Systems Inc|Price:49.750|Chg%:+0.560 - TradingKey
Inspire Medical Systems, Inc. Revenue Breakdown – BOATS:INSP - TradingView
Inspire Medical Systems Inc (INSP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inspire Medical Systems (INSP) Refreshes Its Board, Is It Still Below Fair Value? - Sahm
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc.INSP - marketscreener.com
INSP|Inspire Medical Systems Inc|Price:49.190|Chg%:-1.620 - TradingKey
INSP|Inspire Medical Systems Inc|Price:50.760|Chg%:+0.360 - TradingKey
Inspire Medical names AtriCure CEO Michael Carrel to board - Bitget
Inspire Medical board member Tansey to retire July 30 By Investing.com - Investing.com Canada
Inspire Medical board member Tansey to retire July 30 - Investing.com
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors - The Manila Times
Casey Tansey to Retire from Inspire's Board, Effective July 30, 2026 - TradingView
After more than 18 years, Casey Tansey to retire from Inspire board - Stock Titan
Inspire Medical Systems (INSP) Q4 2024 earnings summary - Quartr
Inspire Medical (INSP) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
1 Billion People Suffer From Sleep Apena. The Future of Treatment Is No Longer Just CPAP. - Men's Health
A Look at Inspire Medical Systems Inc (INSP) After 5.3% Gain -- GF Value $215.85 vs Price $53.27 - GuruFocus
Form 4 Inspire Medical Systems Inc For: 20 July By Investing.com - Investing.com Nigeria
3 Medical Device Stocks Giving Investors a Different Healthcare Play - MarketBeat
Here's why you should retain INSP stock in your portfolio for now - MSN
Understanding Momentum Shifts in (INSP) - Stock Traders Daily
Price to earnings forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Enterprise value to EBITDA forward of Inspire Medical Systems, Inc. – NYSE:INSP - TradingView
Form 4 Inspire Medical Systems Inc For: 17 July By Investing.com - Investing.com South Africa
Inspire Medical Systems (NYSE: INSP) director receives 581-share stock fee award - Stock Titan
Inspire Medical Systems (INSP) grants director 383 common shares as fees - Stock Titan
ETFs Investing in Inspire Medical Systems, Inc. Stocks - TradingView
Here's Why You Should Retain INSP Stock in Your Portfolio for Now - Yahoo Finance
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $54 - Moomoo
Inspire Medical (INSP) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
INSP Maintained by Truist Securities -- Price Target Raised to $54 - GuruFocus
Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating - Moomoo
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Potential Amidst Robust Revenue Growth in the Medical Device Sector - DirectorsTalk Interviews
Inspire Medical Systems Inc (INSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):